DrugPatentWatch Database Preview
Details for Patent: 8,227,471
» See Plans and Pricing
Which drugs does patent 8,227,471 protect, and when does it expire?
Patent 8,227,471 protects ADDYI and is included in one NDA.
This patent has forty-two patent family members in twenty-nine countries.
Summary for Patent: 8,227,471
| Title: | Treating sexual desire disorders with flibanserin |
| Abstract: | The invention relates to the use of flibanserin, or a pharmaceutically acceptable acid addition salt thereof, for the treatment of disorders of sexual desire. |
| Inventor(s): | Borsini; Franco (Bad Waldsee, DE), Evans; Kenneth Robert (Toronto, CA) |
| Assignee: | Sprout Pharmaceuticals, Inc. (Raleigh, NC) |
| Application Number: | 11/524,268 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 8,227,471
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sprout Pharms | ADDYI | flibanserin | TABLET;ORAL | 022526-001 | Aug 18, 2015 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,227,471
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| 01125020 | Oct 20, 2001 | |
International Family Members for US Patent 8,227,471
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 037109 | Start Trial | |||
| Argentina | 077480 | Start Trial | |||
| Austria | 327757 | Start Trial | |||
| Australia | 2002333894 | Start Trial | |||
| Brazil | 0213358 | Start Trial | |||
| Canada | 2458067 | Start Trial | |||
| China | 101347431 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
